Obesity has raised a worldwide epidemic, Obesity and related consequences have been gaining increased attention in part because of huge financial costs and impact on health, families, and communities. These concerns have made it become the forefront of scientific and mainstream media. All of us are now recognizing the need for more robust strategies and effective interventions to better assess and treat obesity.Obesity is the “excess deposition of adipose tissue to extent that impairs physical and psychosocial health as well as well-being”. 1 Obesity a global health problem affecting subjects of all ages. Fighting obesity is one of the 21st century major challenges. Falling obese triggers the vicious cycle of obesity-exercise intolerance, the stat in which obese subjects assumes the sedentary lifestyle. 2Central (abdominal) obesity is strongly correlated with increased cardiovascular risks and other metabolic disturbances, even more than total body adipose mass. 3, 4 Obesity-related chronic conditions cause direct and indirect health care costs. Increasing BMI is tightly linked to increased medication use, visits to hospital emergency departments, and visits to outpatient clinics 5, 6 Furthermore; all major health risks are in parallel with increased measures of abdominal obesity. 7Obesity is commonly linked with increased disability risk and health-related costs 8, 9 Functional performance and physical ability are usually deteriorated in obese subjects 10, 11 Developed as well as developing world are all suffering the negative impact of obesity as a key risk factor for other debilitating disorders as diabetes, cancer, osteoarthritis and cardiovascular events. The obesity-related dysfunctions affect not only adults -as was previously seen-; but also affecting young age groups. Childhood and adolescent hood obesity is associated with early physical deconditioning as well as later increase in health hazards. 12Obesity-related medical problems affect huge number which exceeds 115 million individuals according to WHO in developing countries. Moreover; these disorders will be the number one of death cause among these population by 2030. 12 Obesity is the fifth leading threat for deaths worldwide. Approximately 2.8 million adults die annually because of being obese. 13 Half deaths in the developing countries are due to obesity-related chronic diseases. This percentage exceeds that of deaths due to communicable disease and injuries. 14Middle Eastern countries of Bahrain, Saudi Arabia, Egypt, Jordan, Tunisia, and Lebanon exhibit alarming prevalence levels of obesity. 15, 16 Gulf Cooperation Council (GCC; Saudi Arabia, Bahrain, Qatar, Oman, Kuwait and United Arab Emirates) countries have one of the highest prevalence of obese adults ranging from 10-60%. Saudi Arabia has the second highest prevalence of obesity (50%) after Kuwait. 17 Obesity becomes one of the most alarming public health problems in in Saudi Arabia. 18, 19Control of obesity is essential to reduce the frequency of other serious disorders. The primary concern in obesity management is reduction of morbidity and mortality risks by improving the underlying cardiovascular risk factors 15, 20 since the prevalence of obesity is significantly elevated in patients with various chronic disorders. 21 Obesity treatment should be individually tailored, comprehensive programs for the treatment of obesity derived from evidence-based medicine can be only established through multidisciplinary teamwork and availability of collaborating facilities. 22 prevalence of obesity recently grows in an alarming manner in Saudi Arabia, especially in young generations, the situation that requires larger national studies that should target implementing more effective preventive and therapeutic strategies required to alleviate the burden of this obesity epidemic. 23Laser-based devices are used in a broad array of medical and surgical applications and their biological effects have been documented for over 20 years. Quiet recently low-level laser therapy (LLLT) has been used to facilitate tissue repair and healing processes as well as treatment of localized (abdominal) obesity. 24 High Level Laser Therapy; a more recent laser application modality; had been quiet recently investigated for its efficacy. HLLT can be more effective than LLLT due to its more intense and deeper effects 25, 26, 27 Low-intensity lasers have been used in body contouring and treatment of localized abdominal obesity on a relatively wide-spread base, with its effectiveness has been clearly proved in numerous positive situations. High-intensity laser stimulation; because of proved safety in application, may be alternatively used instead of LLLT to obtain more favorable results in a comparable short time duration.
The role of HLILT in treatment localized obesity situations needs further investigation because of the little available literature that concentrated mainly on LLLT or HLLT role in the treatment of musculoskeletal pathologies. No literature – up till now- manipulates the role of HLLT in treating obesity through HLLT application on the abdominal region. Adding to that, up to date and up to our knowledge; there isn’t any published paper mention the role of HLLT as a treatment modality for abdominal obesity. So, based on the available literature; using HLLT – with its known good safety profile and very little application risk- to stimulate abdominal and visceral fat losing its contents is of great benefits for obese patients. The exact effect of HLLT on patients with abdominal obesity needs to be objectively evaluated, and that’s we are willing to do.